Author:
Cassier P. A.,Méeus P.,Scoazec J.-Y.,Blay J. Y.
Reference96 articles.
1. Ducimetiere F, Lurkin A, Ranchere-Vince D et al. (2010) [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhone-Alpes region.]. Bull Cancer 97: 629–641
2. Nilsson B, Bumming P, Meis-Kindblom JM et al. (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer 103: 821–829
3. Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG (2005) Gastrointestinal stromal tumors in Iceland, 1990–2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 117: 289–293
4. Monges G, Bisot-Locard S, Blay JY et al. (2010) The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists. Bull Cancer 97: E16–E22
5. Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29: 52–68